Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eagle Pharmaceuticals, Inc. (EGRX)  
$4.00 0.46 (12.99%) as of 4:30 Wed 6/5


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 13,030,000
Market Cap: 52.12(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $3.34 - $22.88
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  634
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eagle Pharmaceuticals is a pharmaceutical company focused on developing medicines to treat diseases of the central nervous system or metabolic critical care therapeutic areas as well as in oncology. Co.'s products include: Belrapzo® (bendamustine ready-to-dilute (RTD) 500ml solution), Bendeka® (infused bendamustine RTD) and Treakisym® for chronic lymphocytic leukemia and non-hodgkin's lymphoma; Ryanodex® (dantrolene sodium) for malignant hyperthermia; EP-4104 Ryanodex® (dantrolene sodium) for the treatment of organophosphate exposure; PEMFEXY™ (pemetrexed for injection) for lung cancer; and EA-114 (fulvestrant) for breast cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 20,245 87,045
Total Sell Value $0 $0 $300,027 $1,741,115
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 2 7
End Date 2024-03-07 2023-12-05 2023-06-06 2022-06-06

   
Records found: 222
  Page 2 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Cahill Brian Joseph Chief Financial Officer   •       –      –    2022-12-19 4 D $30.03 $13,844 D/D (461) 32,206     -
   Edlin Richard A. Director   –       •      –    2022-09-06 4 S $30.99 $210,732 D/D (6,800) 22,600 -5%     
   Cahill Brian Joseph Chief Financial Officer   •       –      –    2022-02-28 4 A $0.00 $0 D/D 8,000 32,667     -
   Moran Michael Shawn EVP, Chief Commercial Officer   •       –      –    2022-02-28 4 A $0.00 $0 D/D 10,400 32,115     -
   Tarriff Scott CEO   •       •       •   2022-02-28 4 A $0.00 $0 D/D 34,800 1,579,706     -
   Moran Michael Shawn EVP, Chief Commercial Officer   •       –      –    2022-02-02 4 D $45.03 $33,412 D/D (742) 21,715     -
   Cahill Brian Joseph Chief Financial Officer   •       –      –    2022-02-02 4 D $45.03 $36,249 D/D (805) 24,667     -
   Moran Michael Shawn EVP, Chief Commercial Officer   •       –      –    2022-01-31 4 D $45.94 $9,647 D/D (210) 22,457     -
   Cahill Brian Joseph Chief Financial Officer   •       –      –    2022-01-31 4 D $45.94 $28,758 D/D (626) 25,472     -
   Moran Michael Shawn EVP, Chief Commercial Officer   •       –      –    2022-01-07 4 D $50.63 $4,557 D/D (90) 22,667     -
   Cahill Brian Joseph Chief Financial Officer   •       –      –    2022-01-07 4 D $50.63 $13,316 D/D (263) 26,098     -
   Moran Michael Shawn EVP, Chief Commercial Officer   •       –      –    2022-01-05 4 D $50.69 $76,593 D/D (1,511) 22,757     -
   Cahill Brian Joseph Chief Financial Officer   •       –      –    2022-01-05 4 D $50.69 $37,409 D/D (738) 26,361     -
   Cahill Brian Joseph Chief Financial Officer   •       –      –    2021-12-20 4 D $55.42 $25,881 D/D (467) 27,099     -
   Moran Michael Shawn EVP, Chief Commercial OfficerO   •       –      –    2021-09-27 3 IO $0.00 $0 D/D 0 24,268 -17%     
   Ratoff Steven B Director   –       •      –    2021-04-08 4 OE $4.42 $51,433 D/D 7,020 27,364     -
   Ng-Cashin Judith Chief Medical Officer   •       –      –    2021-02-02 4 A $0.00 $0 D/D 2,000 2,000     -
   Pernock David Pres & Chief Operating Officer   •       –      –    2021-02-02 4 A $0.00 $0 D/D 9,700 54,625     -
   Cahill Brian Joseph Chief Financial Officer   •       –      –    2021-02-02 4 A $0.00 $0 D/D 8,900 27,566     -
   Cahill Brian Joseph Chief Financial Officer   •       –      –    2021-01-29 4 D $46.67 $29,729 D/D (637) 18,666     -
   Pernock David Pres & Chief Operating Officer   •       –      –    2021-01-23 4 D $47.70 $90,248 D/D (1,892) 44,925     -
   Tarriff Scott CEO   •       •       •   2021-01-23 4 D $47.70 $220,899 D/D (4,631) 1,546,323     -
   Cahill Brian Joseph Chief Financial Officer   •       –      –    2021-01-07 4 D $50.97 $12,080 D/D (237) 14,303     -
   Pernock David Pres & Chief Operating Officer   •       –      –    2021-01-07 4 D $50.97 $46,179 D/D (906) 46,817     -
   Pernock David Pres & Chief Operating Officer   •       –      –    2021-01-05 4 D $50.02 $104,442 D/D (2,088) 47,723     -
  222 Records found
  1  2  3  4  5  6  7  8  9   
  Page 2 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us